Moreover, integrated biomarker discovery from multiple sample types including lung cancer tissues, cell lines and conditioned medium has established to construct a biomarker model (TFPI, MDK, OPN, MMP2, TIMP1, CEA, CYFRA 21–1, SCC) which enables to classify lung cancer patients from high risk smokers [8]. This evidence concerns the gene MMP2 and lung cancer.